Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification
Clinical trial NCT02626364 · COMPLETED
Trial details
- NCT number
- NCT02626364
- Sponsor
- Arog Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2020-07-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.